PMV Pharmaceuticals, Inc. (PMVP)
1.27
-0.04
(-2.68%)
USD |
NASDAQ |
Oct 23, 16:00
1.275
0.00 (0.00%)
After-Hours: 20:00
PMV Pharmaceuticals Net Income (Quarterly) : -18.09M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -18.09M |
| March 31, 2026 | -18.04M |
| December 31, 2025 | -18.04M |
| September 30, 2025 | -21.06M |
| June 30, 2025 | -21.21M |
| March 31, 2025 | -17.44M |
| December 31, 2024 | -23.00M |
| September 30, 2024 | -19.23M |
| June 30, 2024 | -1.213M |
| March 31, 2024 | -15.27M |
| December 31, 2023 | -15.76M |
| September 30, 2023 | -16.64M |
| June 30, 2023 | -17.44M |
| March 31, 2023 | -19.13M |
| Date | Value |
|---|---|
| December 31, 2022 | -19.34M |
| September 30, 2022 | -18.23M |
| June 30, 2022 | -17.31M |
| March 31, 2022 | -18.43M |
| December 31, 2021 | -18.36M |
| September 30, 2021 | -15.01M |
| June 30, 2021 | -12.87M |
| March 31, 2021 | -11.60M |
| December 31, 2020 | -10.45M |
| September 30, 2020 | -8.764M |
| June 30, 2020 | -7.966M |
| March 31, 2020 | -7.255M |
| December 31, 2019 | -7.047M |
| September 30, 2019 | -6.175M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 18.09M |
| EPS Diluted (Quarterly) | -0.3388 |
| Enterprise Value | -11.32M |
| Earnings Yield | -111.3% |
| Normalized Earnings Yield | -111.25 |